EGFR c.478_480delinsTGT ;(p.E160C)

Variant ID: 7-55214352-GAG-TGT

NM_005228.3(EGFR):c.478_480delinsTGT;(p.E160C)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

Oncoimmunology
Tapia-Galisteo, Antonio A; Sánchez Rodríguez, Íñigo Í; Aguilar-Sopeña, Oscar O; Harwood, Seandean Lykke SL; Narbona, Javier J; Ferreras Gutierrez, Mariola M; Navarro, Rocío R; Martín-García, Laura L; Corbacho, Cesáreo C; Compte, Marta M; Lacadena, Javier J; Blanco, Francisco J FJ; Chames, Patrick P; Roda-Navarro, Pedro P; Álvarez-Vallina, Luis L; Sanz, Laura L
Publication Date: 2022

Variant appearance in text: EGFR: E160C
PubMed Link: 35154908
Variant Present in the following documents:
  • Main text
  • KONI_11_2034355.pdf
View BVdb publication page



Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

Oncoimmunology
Tapia-Galisteo, Antonio A; Sánchez Rodríguez, Íñigo Í; Aguilar-Sopeña, Oscar O; Harwood, Seandean Lykke SL; Narbona, Javier J; Ferreras Gutierrez, Mariola M; Navarro, Rocío R; Martín-García, Laura L; Corbacho, Cesáreo C; Compte, Marta M; Lacadena, Javier J; Blanco, Francisco J FJ; Chames, Patrick P; Roda-Navarro, Pedro P; Álvarez-Vallina, Luis L; Sanz, Laura L
Publication Date: 2022

Variant appearance in text: EGFR: E160C
PubMed Link: 35154908
Variant Present in the following documents:
  • Main text
  • KONI_11_2034355.pdf
View BVdb publication page



Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds.

Antibodies (Basel, Switzerland)
Vaks, Lilach L; Litvak-Greenfeld, Dana D; Dror, Stav S; Shefet-Carasso, LeeRon L; Matatov, Galia G; Nahary, Limor L; Shapira, Shiran S; Hakim, Rahely R; Alroy, Iris I; Benhar, Itai I
Publication Date: 2018-07-28

Variant appearance in text: EGFR: E160C
PubMed Link: 31544879
Variant Present in the following documents:
  • antibodies-07-00027.pdf
View BVdb publication page